# Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene

> **NCT04332978** · PHASE3 · COMPLETED · sponsor: **Libbs Farmacêutica LTDA** · enrollment: 566 (actual)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Fluticasone Propionate

## Key facts

- **NCT ID:** NCT04332978
- **Lead sponsor:** Libbs Farmacêutica LTDA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-04
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 566 (ACTUAL)
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04332978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04332978, "Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04332978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*